Literature DB >> 956959

Systemic lupus erythematosus in childhood correlations between changes in disease activity and serum complement levels.

B H Singsen, B H Bernstein, K K King, V Hanson.   

Abstract

Serial complement component (C3 and C4) determinations were performed in 26 children with systemic lupus erythematosus. Twenty-one children with SLE had 52 episodes of C3 depression (mean duration 25 weeks); only 11 of these children had active nephritis when serum concentrations of complement were depressed. Fourteen children had active rash associated with low C3; in seven of these children rash was the only clinical evidence of disease activity. Ten children had active CNS disease; in seven children the CNS involvement correlated with low C3. In general, variations in serum concentrations of C4 did not reflect changes in SLE activity which were not reflected by changes in serum concentrations of C3. Serum C4 occasionally remained depressed longer than C3, perhaps reflecting continuing subclinical disease activity. Increased C3 occurred in 18 of 26 children as doses of corticosteroid were increased, in six of 14 when cyclophosphamide was added, and in two children when hydroxychloroquine was added. Our findings suggest that a wide variety of manifestations of childhood SLE may produce hypocomplementemia. In addition to renal disease, variations in serum concentrations of C3 and C4 can reflect, or occasionally predict, changes in rash and CNS disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956959     DOI: 10.1016/s0022-3476(76)80528-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

Review 1.  Systemic lupus erythematosus.

Authors:  M S Klein-Gitelman; M L Miller
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

Review 2.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

3.  Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels.

Authors:  Hiroyuki Wakiguchi; Syuji Takei; Tomohiro Kubota; Akinori Miyazono; Yoshifumi Kawano
Journal:  Clin Rheumatol       Date:  2016-11-30       Impact factor: 2.980

4.  Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis.

Authors:  E H Garin; J W Sleasman; G A Richard; A A Iravani; R S Fennell
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

5.  A long-term immunological study of childhood onset systemic lupus erythematosus.

Authors:  C K Ting; K H Hsieh
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

6.  Systemic lupus erythematosus presenting as chorea.

Authors:  L F Kukla; C Reddy; G Silkalns; M Prasad
Journal:  Arch Dis Child       Date:  1978-04       Impact factor: 3.791

Review 7.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.